Birdie Biopharmaceuticals HK Limited

Birdie Biotech Inc. operates as a research and development biopharmaceutical company that focuses on developing therapies for the treatment of cancer and autoimmune disease. Its intellectual property portfolio comprises various patent families relating to targeted TLAC technology and therapy molecules.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.birdiebio.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
JB1-4-013 1 Xiushui St. Chaoyang Dist., 100600
Beijing
China
Email
Contact Number
86 8325 6257

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]